EDGAR Filing Documents for 0001047469-15-007903

Form 424B4 - Prospectus [Rule 424(b)(4)]:

SEC Accession No. 0001047469-15-007903

Filing Date

2015-10-16

Accepted

2015-10-16 16:29:22

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B4	a2226274z424b4.htm	424B4	3298763
2	G400376.JPG	g400376.jpg	GRAPHIC	20191
3	G456181.JPG	g456181.jpg	GRAPHIC	121631
4	G815679.JPG	g815679.jpg	GRAPHIC	42419
5	G715597.JPG	g715597.jpg	GRAPHIC	34175
6	G454757.JPG	g454757.jpg	GRAPHIC	17289
7	G852078.JPG	g852078.jpg	GRAPHIC	30729
	Complete submission text file	0001047469-15-007903.txt		3667617

Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053

Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200

Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: 424B4 | Act: 33 | File No.: 333-206654 | Film No.: 151162303
SIC: 2834 Pharmaceutical Preparations